Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793442 · ClinicalTrials.gov registry record
Endothelium in Severe Sepsis
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 910
- Enrollment target
NCT00793442 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 910 participants.
The verdict
NCT00793442 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 910 participants
- Enrollment target
Study Summary
The overall hypotheses of this project is that severe sepsis is associated with endothelial dysfunction; that endothelial dysfunction, in turn, is predictive of subsequent organ failure and death; and that protocolized resuscitation attenuates endothelial cell (EC) dysfunction and improves patient survival.
Interventions
- DIAGNOSTIC_TEST Blood Collection and Assays
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 910 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793442
The ClinicalTrials.gov registry entry for NCT00793442 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 910 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Collection and Assays is the first listed.
NCT00793442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793442 about?
NCT00793442 is a clinical study titled "Endothelium in Severe Sepsis". The overall hypotheses of this project is that severe sepsis is associated with endothelial dysfunction; that endothelial dysfunction, in turn, is predictive of subsequent organ failure and death; and that protocolized resuscitation attenuates endothelial cell (EC) dysfunction and improves patient s...
What is the current status of trial NCT00793442?
This trial is currently completed. The enrollment target is 910 participants. The study started on 2008-03. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00793442?
The interventions under investigation include: Blood Collection and Assays (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00793442?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.